nightkalalu Posted June 11, 2020 Report Posted June 11, 2020 CHICAGO (Reuters) - Moderna Inc (MRNA.O) on Thursday confirmed it plans to start a trial of 30,000 volunteers of its much-anticipated coronavirus vaccine in July as the company enters the final stage of testing. The Cambridge, Massachusetts-based biotech said the primary goal of the study would be to prevent symptomatic COVID-19, the disease caused by the novel coronavirus. The key secondary goal would be prevention of severe disease, as defined by keeping people out of the hospital. The company’s shares jumped 6 percent in premarket trading. Vaccine in 2020🤞 Quote
r2d2 Posted June 11, 2020 Report Posted June 11, 2020 not sure if this positive news is enough to shore up the market.. Quote
Sachin200 Posted June 11, 2020 Report Posted June 11, 2020 Important testing phase & crucial phase Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.